These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22646142)

  • 1. Antigen-matched red blood cell transfusions for patients with sickle cell disease at The Johns Hopkins Hospital.
    Karafin MS; Shirey RS; Ness PM; King KE
    Immunohematology; 2012; 28(1):3-6. PubMed ID: 22646142
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells.
    Vichinsky EP
    Immunohematology; 2012; 28(1):20-3. PubMed ID: 22646146
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfusion practices for patients with sickle cell disease at the Children's Hospital of Philadelphia.
    Chou ST; Friedman DF
    Immunohematology; 2012; 28(1):27-30. PubMed ID: 22646148
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfusion protocol for patients with sickle hemoglobinopathies at Children's National Medical Center.
    Fasano RM; Paul W; Siegal E; Luban NL
    Immunohematology; 2012; 28(1):13-6. PubMed ID: 22646144
    [No Abstract]   [Full Text] [Related]  

  • 5. Transfusions for patients with sickle cell disease at Children's Hospital Boston.
    Sloan SR
    Immunohematology; 2012; 28(1):17-9. PubMed ID: 22646145
    [No Abstract]   [Full Text] [Related]  

  • 6. Red blood cell alloimmunization: lessons from sickle cell disease.
    Treml A; King KE
    Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994
    [No Abstract]   [Full Text] [Related]  

  • 7. Directed blood donor program decreases donor exposure for children with sickle cell disease requiring chronic transfusion.
    Roberts DO; Covert B; Lindsey T; Edwards V; McLaughlin L; Theus J; Wray RJ; Jupka K; Baker D; Robbins M; DeBaun MR
    Immunohematology; 2012; 28(1):7-12. PubMed ID: 22646143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion practices for patients with sickle cell disease at major academic medical centers participating in the Atlanta Sickle Cell Consortium.
    Winkler AM; Josephson CD
    Immunohematology; 2012; 28(1):24-6. PubMed ID: 22646147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
    Miller ST; Kim HY; Weiner DL; Wager CG; Gallagher D; Styles LA; Dampier CD; Roseff SD;
    Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood bank issues associated with red cell exchanges in sickle cell disease.
    Sarode R; Altuntas F
    J Clin Apher; 2006 Dec; 21(4):271-3. PubMed ID: 17177280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
    Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
    Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.
    Chou ST; Jackson T; Vege S; Smith-Whitley K; Friedman DF; Westhoff CM
    Blood; 2013 Aug; 122(6):1062-71. PubMed ID: 23723452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell alloimmunization in sickle cell disease-prevalence and trends: a single-center cross-sectional study from United Kingdom.
    Mijovic A; Perera IG; Thein SL
    Transfusion; 2013 Dec; 53(12):3279-80. PubMed ID: 24320815
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients].
    Diarra AB; Guindo A; Kouriba B; Dorie A; Diabaté DT; Diawara SI; Fané B; Touré BA; Traoré A; Gulbis B; Diallo DA
    Transfus Clin Biol; 2013 Dec; 20(5-6):476-81. PubMed ID: 23916574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of molecular immunohematology in sickle cell disease.
    Chou ST; Westhoff CM
    Transfus Apher Sci; 2011 Feb; 44(1):73-9. PubMed ID: 21277259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease.
    Karafin MS; Field JJ; Gottschall JL; Denomme GA
    Transfusion; 2015 Jun; 55(6 Pt 2):1399-406. PubMed ID: 25757390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosensitization in patients receiving multiple blood transfusions.
    Sakhalkar VS; Roberts K; Hawthorne LM; McCaskill DM; Veillon DM; Caldito GC; Cotelingam JD
    Ann N Y Acad Sci; 2005; 1054():495-9. PubMed ID: 16339705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How I manage red cell transfusions in patients with sickle cell disease.
    Rees DC; Robinson S; Howard J
    Br J Haematol; 2018 Feb; 180(4):607-617. PubMed ID: 29377071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion therapy for sickle cell disease: a balancing act.
    Chou ST
    Hematology Am Soc Hematol Educ Program; 2013; 2013():439-46. PubMed ID: 24319217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.